Correction to the Trends From the Field article, “Health Literacy, Preventive Health Screening, and Medication Adherence Behaviors of Older African Americans at a PCMH,” published in the September 2018 issue of The American Journal of Managed Care®.
Am J Manag Care. 2019;25(5):256The authors of the Trends From the Field article, “Health Literacy, Preventive Health Screening, and Medication Adherence Behaviors of Older African Americans at a PCMH,” published in the September 2018 issue of The American Journal of Managed Care®, have issued this statement to clarify and correct any misunderstanding caused by the abbreviations used for describing the medication adherence scale mentioned across various segments (Abstract, Methods, Results, Discussion, and Table 2) of the article.1
The medication adherence scale used in the study for the authors’ article was the Self-reported Medication-taking Scale published in 1986 by Morisky et al.2 The authors inadvertently referred to the scale as the Morisky Medication Adherence Scale and abbreviated it as MMAS. Any confusion from the inadvertent reference to the Morisky Medication Adherence Scale, as well as the use of the acronym MMAS to refer to the Self-reported Medication-taking Scale, was unintentional.
REFERENCES
1. Aranha ANF, Patel PJ. Health literacy, preventive health screening, and medication adherence behaviors of older African Americans at a PCMH. Am J Manag Care. 2018;24(9):428-432.
2. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More